Where can I find USNA's financial statements?

USANA Health Sciences, Inc. (USNA)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.

How much history is available for USNA?

USANA Health Sciences, Inc. (USNA) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.

How often does USNA update its statements?

USANA Health Sciences, Inc. files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

USNA

USANA Health Sciences, Inc.

NYSE·Household & Personal Products · Consumer Defensive

$22.16$0.04+0.18%

After hours·$22.52+1.62%

Market cap$409.14M·Market closed·Jul 22 8:00 PM UTC

USD · values shown as reported

Line item	FY 2021	FY 2022	FY 2023	FY 2024	FY 2026	Trend
Revenue	$1.19B+4.6%	$998.60M−15.8%	$921.01M−7.8%	$854.50M−7.2%	$925.26M+8.3%
Cost of revenue	$230.93M+3.6%	$207.28M−10.2%	$189.40M−8.6%	$175.75M−7.2%	$200.85M+14.3%
Gross profit	$955.53M+4.8%	$791.32M−17.2%	$731.62M−7.5%	$678.75M−7.2%	$724.41M+6.7%
Research & development	$11.11M+4.5%	$11.56M+4.1%	$11.45M−1.0%	$11.57M+1.1%	—
General & administrative	—	—	—	—	$337.37M	—
SG&A (combined)	$774.23M+6.8%	$672.14M−13.2%	$627.10M−6.7%	$600.86M−4.2%	$337.37M−43.9%
Other operating expenses	—	—	—	—	$336.17M
Total operating expenses	$785.34M+6.8%	$683.70M−12.9%	$638.54M−6.6%	$612.43M−4.1%	$673.54M+10.0%
Operating income	$170.19M−3.6%	$107.61M−36.8%	$93.07M−13.5%	$66.32M−28.7%	$50.86M−23.3%
Interest income	$2.52M−0.8%	$3.79M+50.7%	$9.64M+154.3%	$11.32M+17.5%	$2.42M−78.7%
Interest expense	$57.00K−88.8%	$192.00K+236.8%	$262.00K+36.5%	$281.00K+7.3%	$842.00K+199.6%
Other income / (expense), net	$450.00K−69.1%	$1.01M+123.8%	$9.38M+831.7%	$10.03M+6.9%	−$9.34M−193.1%
Income before tax	$170.64M−4.1%	$108.62M−36.3%	$102.45M−5.7%	$76.35M−25.5%	$41.53M−45.6%
Income tax expense	$54.14M+1.6%	$39.27M−27.5%	$38.67M−1.5%	$34.29M−11.3%	$30.05M−12.4%
Net income	$116.51M−6.5%	$69.35M−40.5%	$63.79M−8.0%	$42.03M−34.1%	$10.76M−74.4%

EPS (basic)	$5.78−1.9%	$3.60−37.7%	$3.33−7.5%	$2.20−33.9%	$0.58−73.6%
EPS (diluted)	$5.73−2.2%	$3.59−37.3%	$3.30−8.1%	$2.19−33.6%	$0.58−73.5%
Weighted avg shares (basic)	20,146,000	19,254,000	19,250,000	19,064,000	18,574,000
Weighted avg shares (diluted)	20,343,000	19,310,000	19,345,000	19,162,000	18,574,000

Depreciation & amortization	$22.19M−1.4%	$21.41M−3.5%	$20.40M−4.7%	$22.23M+9.0%	$39.70M+78.6%
EBITDA	$192.89M−4.0%	$130.22M−32.5%	$123.11M−5.5%	$98.86M−19.7%	$82.07M−17.0%

Frequently Asked Questions About USNA

Where can I find USNA's financial statements?: USANA Health Sciences, Inc. (USNA)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.
How much history is available for USNA?: USANA Health Sciences, Inc. (USNA) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.
How often does USNA update its statements?: USANA Health Sciences, Inc. files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

Line item

FY 2021

FY 2022

FY 2023

FY 2024

FY 2026

Trend

Revenue

$1.19B+4.6%

$998.60M−15.8%

$921.01M−7.8%

$854.50M−7.2%

$925.26M+8.3%

Cost of revenue

$230.93M+3.6%

$207.28M−10.2%

$189.40M−8.6%

$175.75M−7.2%

$200.85M+14.3%

Gross profit

$955.53M+4.8%

$791.32M−17.2%

$731.62M−7.5%

$678.75M−7.2%

$724.41M+6.7%

Research & development

$11.11M+4.5%

$11.56M+4.1%

$11.45M−1.0%

$11.57M+1.1%

—

General & administrative

—

$337.37M

—

SG&A (combined)

$774.23M+6.8%

$672.14M−13.2%

$627.10M−6.7%

$600.86M−4.2%

$337.37M−43.9%

Other operating expenses

—

$336.17M

Total operating expenses

$785.34M+6.8%

$683.70M−12.9%

$638.54M−6.6%

$612.43M−4.1%

$673.54M+10.0%

Operating income

$170.19M−3.6%

$107.61M−36.8%

$93.07M−13.5%

$66.32M−28.7%

$50.86M−23.3%

Interest income

$2.52M−0.8%

$3.79M+50.7%

$9.64M+154.3%

$11.32M+17.5%

$2.42M−78.7%

Interest expense

$57.00K−88.8%

$192.00K+236.8%

$262.00K+36.5%

$281.00K+7.3%

$842.00K+199.6%

Other income / (expense), net

$450.00K−69.1%

$1.01M+123.8%

$9.38M+831.7%

$10.03M+6.9%

−$9.34M−193.1%

Income before tax

$170.64M−4.1%

$108.62M−36.3%

$102.45M−5.7%

$76.35M−25.5%

$41.53M−45.6%

Income tax expense

$54.14M+1.6%

$39.27M−27.5%

$38.67M−1.5%

$34.29M−11.3%

$30.05M−12.4%

Net income

$116.51M−6.5%

$69.35M−40.5%

$63.79M−8.0%

$42.03M−34.1%

$10.76M−74.4%

EPS (basic)

$5.78−1.9%

$3.60−37.7%

$3.33−7.5%

$2.20−33.9%

$0.58−73.6%

EPS (diluted)

$5.73−2.2%

$3.59−37.3%

$3.30−8.1%

$2.19−33.6%

$0.58−73.5%

Weighted avg shares (basic)

20,146,000

19,254,000

19,250,000

19,064,000

18,574,000

Weighted avg shares (diluted)

20,343,000

19,310,000

19,345,000

19,162,000

18,574,000

Depreciation & amortization

$22.19M−1.4%

$21.41M−3.5%

$20.40M−4.7%

$22.23M+9.0%

$39.70M+78.6%

EBITDA

$192.89M−4.0%

$130.22M−32.5%

$123.11M−5.5%

$98.86M−19.7%

$82.07M−17.0%